erythromycin has been researched along with Neuroblastoma in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alfonso, A; Alonso, E; Botana, LM; Ebel, R; Houssen, WE; Jaspars, M; Leirós, M; Rateb, ME; Sanchez, JA | 1 |
| Haitao, Y; Jianquan, Z; Xiaoli, W; Xiaoyan, L; Xiaoyun, M; Xin, L; Yongsheng, J | 1 |
| Colla, M; Endres, M; Gertz, K; Hellmann-Regen, J; Kronenberg, G; Uhlemann, R | 1 |
| Flynn, PM; Hughes, WT; Pui, CH; Santana, VM; Shenep, JL; Vargas, SL | 1 |
4 other study(ies) available for erythromycin and Neuroblastoma
| Article | Year |
|---|---|
Mitigation of ROS insults by Streptomyces secondary metabolites in primary cortical neurons.
Topics: Animals; Anti-Bacterial Agents; Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone; Carboxylic Ester Hydrolases; Cells, Cultured; Cerebral Cortex; Cytosol; Embryo, Mammalian; Erythromycin; Humans; L-Lactate Dehydrogenase; Membrane Potential, Mitochondrial; Mice; Neuroblastoma; Neurons; NF-E2-Related Factor 2; Proton Ionophores; Reactive Oxygen Species; Signal Transduction; Streptomyces | 2014 |
Antitumor activity of erythromycin on human neuroblastoma cell line (SH-SY5Y).
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cyclin-Dependent Kinase Inhibitor p21; Erythromycin; Humans; Neuroblastoma; Proto-Oncogene Proteins c-myc | 2011 |
Retinoic acid as target for local pharmacokinetic interaction with modafinil in neural cells.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Antineoplastic Agents; Benzhydryl Compounds; Cell Differentiation; Cell Line, Tumor; Cytochrome P-450 CYP3A; Dopamine; Erythromycin; Gene Expression Regulation, Neoplastic; Green Fluorescent Proteins; Humans; Mice; Modafinil; Neuroblastoma; Neurofilament Proteins; Neurons; Neuroprotective Agents; Phosphopyruvate Hydratase; Protein Synthesis Inhibitors; Transfection; Tretinoin | 2012 |
Azithromycin for treatment of severe Cryptosporidium diarrhea in two children with cancer.
Topics: Administration, Oral; Azithromycin; Child, Preschool; Combined Modality Therapy; Cryptosporidiosis; Diarrhea; Diarrhea, Infantile; Drug Evaluation; Erythromycin; Fluid Therapy; Humans; Infant; Male; Mediastinal Neoplasms; Neuroblastoma; Opportunistic Infections; Sarcoma | 1993 |